How does ResMed (RMD) make money?

ResMed (RMD) primarily makes money through Sleep And Respiratory, which accounts for 87.9% of total revenue. For TTM through Q4 2025, ResMed generated $5.40B in total revenue with a net profit margin of 27.5%.

What is ResMed (RMD) gross profit margin?

ResMed (RMD) reported a gross profit margin of 61% for TTM through Q4 2025, equivalent to $3.29B in gross profit. This means ResMed retains 61% of each revenue unit after direct costs of production.

What is ResMed (RMD) operating profit margin?

ResMed (RMD) reported an operating profit margin of 33.8% for TTM through Q4 2025, equivalent to $1.82B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is ResMed (RMD) net profit margin?

ResMed (RMD) reported a net profit margin of 27.5% for TTM through Q4 2025, equivalent to $1.49B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does ResMed (RMD) invest in R&D?

ResMed (RMD) invested $348.68M in research and development in TTM through Q4 2025 (6.5% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does ResMed (RMD) spend on capital expenditures?

ResMed (RMD) spent $125.88M on capital expenditures in TTM through Q4 2025 (2.3% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is ResMed (RMD) free cash flow?

ResMed (RMD) generated $1.79B in free cash flow for TTM through Q4 2025 (33.1% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

What is ResMed (RMD) effective tax rate?

ResMed (RMD) had an effective tax rate of 18.3% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

How ResMed (RMD) Makes Money: A Visual Guide

ResMed (RMD) generated $5.40B in revenue, earning $1.49B in net profit (27.5% margin). Its largest revenue source is Sleep And Respiratory (87.9% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.

ResMed (RMD) Income Statement Flow — TTM through Q4 2025

Calculated from the four most recent reported quarters, ending December 31, 2025 (reported January 30, 2026).

Frequently asked questions

How does ResMed (RMD) make money?: ResMed (RMD) primarily makes money through Sleep And Respiratory, which accounts for 87.9% of total revenue. For TTM through Q4 2025, ResMed generated $5.40B in total revenue with a net profit margin of 27.5%.
What is ResMed (RMD) gross profit margin?: ResMed (RMD) reported a gross profit margin of 61% for TTM through Q4 2025, equivalent to $3.29B in gross profit. This means ResMed retains 61% of each revenue unit after direct costs of production.
What is ResMed (RMD) operating profit margin?: ResMed (RMD) reported an operating profit margin of 33.8% for TTM through Q4 2025, equivalent to $1.82B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is ResMed (RMD) net profit margin?: ResMed (RMD) reported a net profit margin of 27.5% for TTM through Q4 2025, equivalent to $1.49B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does ResMed (RMD) invest in R&D?: ResMed (RMD) invested $348.68M in research and development in TTM through Q4 2025 (6.5% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does ResMed (RMD) spend on capital expenditures?: ResMed (RMD) spent $125.88M on capital expenditures in TTM through Q4 2025 (2.3% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is ResMed (RMD) free cash flow?: ResMed (RMD) generated $1.79B in free cash flow for TTM through Q4 2025 (33.1% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is ResMed (RMD) effective tax rate?: ResMed (RMD) had an effective tax rate of 18.3% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q4 2025.